SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-14-000050
Filing Date
2014-05-07
Accepted
2014-05-07 17:30:39
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-331201410q.htm 10-Q 934427
2 EXHIBIT-CERTIFICATION lgnd-ex311_3312014.htm EX-31.1 13698
3 EXHIBIT-CERTIFICATION lgnd-ex312_3312014.htm EX-31.2 13631
4 EXHIBIT-CERTIFICATION lgnd-ex321_3312014.htm EX-32.1 8516
5 EXHIBIT-CERTIFICATION lgnd-ex322_3312014.htm EX-32.2 8348
  Complete submission text file 0000886163-14-000050.txt   9241890

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20140331.xml EX-101.INS 1657537
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20140331.xsd EX-101.SCH 53537
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20140331_cal.xml EX-101.CAL 74985
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20140331_def.xml EX-101.DEF 194894
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20140331_lab.xml EX-101.LAB 777389
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20140331_pre.xml EX-101.PRE 393578
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 14822182
SIC: 2834 Pharmaceutical Preparations